Dr. Jeff Ratliff talks with Prof. Andrew Siderowf about the assessment of heterogeneity among participants in the Parkinson progression markers initiative cohort using α-synuclein seed amplification.

Read the related article in The Lancet Neurology.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Nico Dosenbach about topographic brain organization and redrawing the homunculus.

Read the related article in Nature. 

Disclosures can be found at Neurology.org.

Dr. Farrah Mateen talks with Dr. Deanna Saylor about proposed competencies that can serve as a basis for global neurology training programs.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.

Read the related article on the FDA website. 

Disclosures can be found at Neurology.org

Dr. Jason Crowell talks with Dr. Farrah Mateen about clinical information that neurologists and other clinicians can use to treat people who are forcibly displaced.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022. 

Read the related article in The Lancet.

Disclosures can be found at Neurology.org.

Dr. Tesha Monteith talks with Dr. Mark Burish about circadian-targeted research into cluster headaches and migraines.

Read the related article in Neurology. 

Disclosures can be found at Neurology.org

Dr. Jason Crowell talks with Dr. Sophie Cho, Program Director in the Division of Clinical Research at NINDS, about the state of Parkinson disease research.

For links to previous podcast episodes, please visit NPUb.org/Podcast.

Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Raúl Martínez-Fernández about the long-term outcome of unilateral FUS-STN treatment for Parkinson disease.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Cost Burden of MS in the US:  Retinal and Cortical Atrophy in MS:  Association of EBV and Multiple Sclerosis https://directory.libsyn.com/episode/index/id/22394066

https://directory.libsyn.com/episode/index/id/25428246

https://directory.libsyn.com/episode/index/id/26217204

The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs: https://n.neurology.org/content/98/18/e1810

Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials: https://n.neurology.org/content/100/4/e357